Degradation of hollow mesoporous silica nanoparticles in human umbilical vein endothelial cells

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 100 B, Issue 5, 2012, Pages 1397-1403

  Zhai, Wanyin ^a   He, Changliang ^b   Wu, Lei ^c   Zhou, Yue ^d   Chen, Hangrong ^a   Chang, Jiang ^a   Zhang, Hongfeng ^b  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

^c SHANGHAI INSTITUTE OF MICROSYSTEM AND INFORMATION TECHNOLOGY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cytoplasm; Degradation; Endothelial cell; Lysosome; Mesoporous silica nanoparticles

Indexed keywords

CULTURE MEDIUM; CYTOPLASM; DEGRADATION PRODUCTS; DRUG LOADING; ENZYMATIC PROTEOLYSIS; FLUORESCENCE STAINING; HOLLOW MESOPOROUS SILICA NANOPARTICLES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; INDUCTIVELY COUPLED PLASMA ATOMIC EMISSION SPECTROSCOPY; LYSOSOME; MESOPOROUS SILICA NANOPARTICLES; POTENTIAL DRUG; SI CONTENT; SILICA NANOPARTICLES;

ATOMIC EMISSION SPECTROSCOPY; CELL CULTURE; DEGRADATION; DRUG DELIVERY; INDUCTIVELY COUPLED PLASMA; LOADING; TRANSMISSION ELECTRON MICROSCOPY;

ENDOTHELIAL CELLS;

HOLLOW MESOPOROUS SILICA NANOPARTICLE; NANOPARTICLE; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC EMISSION SPECTROMETRY; CULTURE MEDIUM; CYTOPLASM; ENZYME DEGRADATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LYSOSOME; TRANSMISSION ELECTRON MICROSCOPY; UMBILICAL VEIN ENDOTHELIAL CELL;

CELLS, CULTURED; CYTOPLASM; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LYSOSOMES; NANOPARTICLES; SILICON DIOXIDE; TIME FACTORS;

EID: 84862223806     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.32711     Document Type: Article

References (32)

1. Slowing II., Vivero-Escoto JL, Wu CW, Lin VSY. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 2008;60:1278-1288.
2. Vallet-Regí M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed 2007;46:7548-7558. (Pubitemid 47556998)
3. Vallet-Regí M, Rámila A, Real RPl, Perez-Pariente J. A new property of MCM-41: Drug delivery system. Chem Mater 2001;13:308-311. (Pubitemid 32199334)
4. Zhu Y, Shi J, Shen W, Dong X, Feng J, Ruan M and Li Y. Stimuliresponsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure. Angew Chem Int Ed 2005;44:5083-5087. (Pubitemid 41199825)
5. Zhu Y, Shi J, Chen H, Shen W, Dong X. A facile method to synthesize novel hollow mesoporous silica spheres and advanced storage property. Micropor Mesopor Mater 2005;84:218-222. (Pubitemid 41764829)
6. Song SW, Hidajat K, Kawi S. Functionalized SBA-15 materials as carriers for controlled drug delivery: Influence of surface properties on matrix-drug interactions. Langmuir 2005;21:9568-9575. (Pubitemid 41507008)
7. Qu F, Zhu G, Lin H, Zhang W, Sun J, Li S, Qiu S. A controlled release of ibuprofen by systematically tailoring the morphology of mesoporous silica materials. J Solid State Chem 2006;179:2027-2035. (Pubitemid 43867553)
8. Shen SC, Ng WK, Shi Z, Chia L, Neoh KG, Tan RBH. Mesoporous silica nanoparticle-functionalized poly(methyl methacrylate)-based bone cement for effective antibiotics delivery. J Mater Sci Mater Med 2011;22:2283-2292.
9. Qu F, Zhu G, Huang S, Li S, Sun J, Zhang D, Qiu S. Controlled release of captopril by regulating the pore size and morphology of ordered mesoporous silica. Micropor Mesopor Mater 2006;92:1-9. (Pubitemid 43782508)
10. Lu J, Liong M, Zink JI, Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 2007;3:1341-1346. (Pubitemid 47245524)
11. Angelos S, Liong M, Choi E, Zink JI. Mesoporous silicate materials as substrates for molecular machines and drug delivery. Chem Eng J 2008;137:4-13. (Pubitemid 351226627)
12. Zhang J, Postovit LM, Wang D, Gardiner RB, Harris R, Abdul MM, Thomas AA. In situ loading of basic fibroblast growth factor within porous silica nanoparticles for a prolonged release. Nanoscale Res Lett 2009;4:1297-1302.
13. Shah DA, Kwon SJ, Bale SS, Banerjee A, Dordick JS, Kane RS. Regulation of stem cell signaling by nanoparticle-mediated intracellular protein delivery. Biomaterials 2011;32:3210-3219.
14. He Q, Zhang J, Chen F, Limin Guo; Ziyan Zhu; Jianlin Shi. An anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles. Biomaterials 2010;31:7785-7796.
15. Park JS, Nab K, Woo DG, Yang HN, Kim JM, Chung HM, Park KH. Non-viral gene delivery of DNA polyplexed with nanoparticles transfected into human mesenchymal stem cells. Biomaterials 2010;31:124-132.
16. Souris JS, Lee CH, Cheng SH, Chen CT, Yang CS, Ho JA, Mou CY, Lo LW. Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials 2010;31:5564-5574.
17. Pompa PP, Vecchio G, Galeone A, Brunetti V, Sabella S, Maiorano G, Falqui A, Bertoni G, Cingolani R. In vivo toxicity assessment of gold nanoparticles in Drosophila melanogaster. Nano Res 2011;4:405-413.
18. Wang L, Zhao W, Tan W. Bioconjugated silica nanoparticles: Development and applications. Nano Res 2008;1:99-115.
19. Hudson SP, Padera RF, Langer R, Kohane DS. The biocompatibility of mesoporous silicates. Biomaterials 2008;29:4045-4055.
20. Li X, Zhang L, Dong X, Liang J, Shi J. Preparation of mesoporous calcium doped silica spheres with narrow size dispersion and their drug loading and degradation behavior. Micropor Mesopor Mater 2007;102:151-158. (Pubitemid 46603114)
21. Kwak SY, Kriven WM, Wallig MA, Choy JH. Inorganic delivery vector for intravenous injection. Biomaterials 2004;25:5995-6001. (Pubitemid 38747022)
22. Slowing II, Trewyn BG, Lin VSY. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J Am Chem Soc 2007;129:8845-8849. (Pubitemid 47492073)
23. Slowing I, Trewyn BG, Lin VSY. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells, J Am Chem Soc 2006;128:14792-14793. (Pubitemid 44851603)
24. Giri S, Trewyn BG, Stellmaker MP, Lin VS. Stimuli-responsive controlled release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles, Angew Chem Int Ed 2005;44:5038-5044. (Pubitemid 41188539)
25. Huang D-M, Hung Y, Ko BS, Hsu SC, Chen WH, Chien CL, Tsai CP, Kuo CT, Kang JC, Yang CS, Mou CY, Chen YC. Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: Implication for stem cell tracking, FASEB J 2005;19:2014-2016. (Pubitemid 41759749)
26. Rosenholm JM, Peuhu E, Bate-Eya LT, Eriksson JE, Sahlgren C, Lindén M. Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors. Small 2010;6:1234-1241.
27. Zhu Y, Shi J, Shen W, Chen H, Dong X, Ruan M. Preparation of novel hollow mesoporous silica spheres and their sustainedrelease property. Nanotechnology 2005;16:2633-2638. (Pubitemid 41436782)
28. Morelli C, Maris P, Sisci D, Perrotta E, Brunelli E, Perrotta I, Panno ML, Tagarelli A, Versace C, Casula MF, Testa F, Ando S, Nagya JB, Pasqua L. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells. Nanoscale 2011;3:3198-3207.
29. Iversena T-G, Skotlanda T, Sandvig K. Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies. Nano Today 2011;6:176-185.
30. Karp G. Lysosomes. In Karp G, editor. Cell and Molecular Biology: Concepts and Experiments. Peking: John Willey & Sons Inc.; 2005. pp 311-313.
31. Skotland T, Sontum PC, Oulie I. In vitro stability analyses as a model for metabolism of ferromagnetic particles (ClariscanTM), a contrast agent for magnetic resonance imaging. J Pharm Biomed Anal 2002;28:323-329. (Pubitemid 34266911)
32. He Q, Shi J, Zhu M, Chen Y, Chen F. The three-stage in vitro degradation behavior of mesoporous silica in simulated body fluid. Micropor Mesopor Mater 2010;131:314-320.